Clostridium perfringens, the most important of the histotoxic species commonly isolated from clinical specimens, is routinely identified in clinical laboratories by the Nagler reaction (5), but other lecithinase-producing Clostridium species also give a positive reaction (4, 6) . Environmental isolates of C. perfringens have been identified by a reverse CAMP test (2, 3) , but such isolates may differ significantly from clinical isolates (1) . Thus, the reverse CAMP test was evaluated to determine its efficacy in the clinical microbiology laboratory for routine presumptive identification of C. perfringens in clinical specimens.
C. perfringens and other Clostridium species isolated from 140 clinical specimens of various body sites, including blood (35 specimens), abdomen (28), wounds (18), rectum (13), genitals (3), biliary tract (3), lung (2), eye (1), cerebrospinal fluid (2) , and other sources (35), were submitted to three hospitals in Winnipeg, Canada. Cultures were identified by standard laboratory procedures and were inoculated at right angles to within 1 to 2 mm of a P-hemolytic group B Streptococcus streak on sheep blood agar plates. Plates were incubated anaerobically and read after 18 to 24 h. A positive reverse CAMP test showed a "bow-tie" or "reverse arrow" pattern of hemolysis at the junction of the two cultures. Thirty-three clinical specimens, consisting of swabs or aspirates from patients with wounds (7 specimens), abdominal sepsis (14), or other sources (12) in which anaerobic infection was likely, described as "direct inocula", were inoculated as received in the clinical laboratory to reverse CAMP plates on blood agar (BA), BA with vitamin K, or BA with phenylethyl alcohol. The direct inoculum specimens and 20 cooked meat broths inoculated with clinical specimens were examined for C. perfringens and other bacteria as part of routine laboratory work-up and provided controls for the reverse CAMP test. Different personnel were involved in both procedures, and results of the reverse CAMP test were checked independently against the final report sent out by the clinical microbiology laboratory.
Of 98 C. perfringens isolates tested, 94 (96%) were reverse CAMP test positive, 1 test, since the antibody preparation used here inhibits C. perfringens lecithinase as detected by the Nagler reaction (5).
When the more common clinical isolates of Clostridium species were tested, the reverse CAMP test reaction was highly specific for C. perfringens and improved the identification procedures available for the organism. The single isolate of C. butyricum which gave a positive reverse CAMP test reaction raised the possibility offalse-positive reactions, but C. butyricum is not frequently encountered in clinical specimens (6) . Clinical specimens as received in the laboratory and cooked meat broths inoculated with clinical specimens were applied directly to reverse CAMP plates, thus eliminating the customary isolation on BA before testing by the Nagler reaction and significantly reducing the time taken to identify the organism. Numerous isolates were tested on a single reverse CAMP plate, thus lowering the cost of identifying an isolate encountered frequently in the clinical laboratory. Intermediate reactions were apparently infrequent and were readily differentiated from true-positive reactions. The results presented in this report indicate that the reverse CAMP test can be used in clinical microbiology laboratories for the rapid presumptive identification of C. perfringens in clinical specimens.
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